Marie Phelan said she had never heard of MDMA before spotting a flyer seeking veterans suffering from post traumatic stress disorder. Now, she says the psychoactive drug more commonly known as ecstasy or molly has changed the trajectory of her life. "My experience of MDMA was that it just cracked my heart wide open," said
Piotr Swat | Lightrocket | Getty Images An experimental lung cancer drug from Akeso and Summit Therapeutics reduced the risk of death by 34% in a closely watched late-stage trial, according to results released Sunday. When combined with chemotherapy, the drug kept people with squamous non-small-cell lung cancer alive for a median of four months
Marie Phelan said she had never heard of MDMA before spotting a flyer seeking veterans suffering from post traumatic stress disorder. Now, she says the psychoactive drug more commonly known as ecstasy or molly has changed the trajectory of her life. "My experience of MDMA was that it just cracked my heart wide open," said
Piotr Swat | Lightrocket | Getty Images An experimental lung cancer drug from Akeso and Summit Therapeutics reduced the risk of death by 34% in a closely watched late-stage trial, according to results released Sunday. When combined with chemotherapy, the drug kept people with squamous non-small-cell lung cancer alive for a median of four months
Marie Phelan said she had never heard of MDMA before spotting a flyer seeking veterans suffering from post traumatic stress disorder. Now, she says the psychoactive drug more commonly known as ecstasy or molly has changed the trajectory of her life. "My experience of MDMA was that it just cracked my heart wide open," said
Piotr Swat | Lightrocket | Getty Images An experimental lung cancer drug from Akeso and Summit Therapeutics reduced the risk of death by 34% in a closely watched late-stage trial, according to results released Sunday. When combined with chemotherapy, the drug kept people with squamous non-small-cell lung cancer alive for a median of four months
Marie Phelan said she had never heard of MDMA before spotting a flyer seeking veterans suffering from post traumatic stress disorder. Now, she says the psychoactive drug more commonly known as ecstasy or molly has changed the trajectory of her life. "My experience of MDMA was that it just cracked my heart wide open," said
Piotr Swat | Lightrocket | Getty Images An experimental lung cancer drug from Akeso and Summit Therapeutics reduced the risk of death by 34% in a closely watched late-stage trial, according to results released Sunday. When combined with chemotherapy, the drug kept people with squamous non-small-cell lung cancer alive for a median of four months
Marie Phelan said she had never heard of MDMA before spotting a flyer seeking veterans suffering from post traumatic stress disorder. Now, she says the psychoactive drug more commonly known as ecstasy or molly has changed the trajectory of her life. "My experience of MDMA was that it just cracked my heart wide open," said
Piotr Swat | Lightrocket | Getty Images An experimental lung cancer drug from Akeso and Summit Therapeutics reduced the risk of death by 34% in a closely watched late-stage trial, according to results released Sunday. When combined with chemotherapy, the drug kept people with squamous non-small-cell lung cancer alive for a median of four months
Marie Phelan said she had never heard of MDMA before spotting a flyer seeking veterans suffering from post traumatic stress disorder. Now, she says the psychoactive drug more commonly known as ecstasy or molly has changed the trajectory of her life. "My experience of MDMA was that it just cracked my heart wide open," said
Piotr Swat | Lightrocket | Getty Images An experimental lung cancer drug from Akeso and Summit Therapeutics reduced the risk of death by 34% in a closely watched late-stage trial, according to results released Sunday. When combined with chemotherapy, the drug kept people with squamous non-small-cell lung cancer alive for a median of four months
Marie Phelan said she had never heard of MDMA before spotting a flyer seeking veterans suffering from post traumatic stress disorder. Now, she says the psychoactive drug more commonly known as ecstasy or molly has changed the trajectory of her life. "My experience of MDMA was that it just cracked my heart wide open," said
Piotr Swat | Lightrocket | Getty Images An experimental lung cancer drug from Akeso and Summit Therapeutics reduced the risk of death by 34% in a closely watched late-stage trial, according to results released Sunday. When combined with chemotherapy, the drug kept people with squamous non-small-cell lung cancer alive for a median of four months
Marie Phelan said she had never heard of MDMA before spotting a flyer seeking veterans suffering from post traumatic stress disorder. Now, she says the psychoactive drug more commonly known as ecstasy or molly has changed the trajectory of her life. "My experience of MDMA was that it just cracked my heart wide open," said
Piotr Swat | Lightrocket | Getty Images An experimental lung cancer drug from Akeso and Summit Therapeutics reduced the risk of death by 34% in a closely watched late-stage trial, according to results released Sunday. When combined with chemotherapy, the drug kept people with squamous non-small-cell lung cancer alive for a median of four months
Marie Phelan said she had never heard of MDMA before spotting a flyer seeking veterans suffering from post traumatic stress disorder. Now, she says the psychoactive drug more commonly known as ecstasy or molly has changed the trajectory of her life. "My experience of MDMA was that it just cracked my heart wide open," said
Piotr Swat | Lightrocket | Getty Images An experimental lung cancer drug from Akeso and Summit Therapeutics reduced the risk of death by 34% in a closely watched late-stage trial, according to results released Sunday. When combined with chemotherapy, the drug kept people with squamous non-small-cell lung cancer alive for a median of four months
Marie Phelan said she had never heard of MDMA before spotting a flyer seeking veterans suffering from post traumatic stress disorder. Now, she says the psychoactive drug more commonly known as ecstasy or molly has changed the trajectory of her life. "My experience of MDMA was that it just cracked my heart wide open," said
Piotr Swat | Lightrocket | Getty Images An experimental lung cancer drug from Akeso and Summit Therapeutics reduced the risk of death by 34% in a closely watched late-stage trial, according to results released Sunday. When combined with chemotherapy, the drug kept people with squamous non-small-cell lung cancer alive for a median of four months
Marie Phelan said she had never heard of MDMA before spotting a flyer seeking veterans suffering from post traumatic stress disorder. Now, she says the psychoactive drug more commonly known as ecstasy or molly has changed the trajectory of her life. "My experience of MDMA was that it just cracked my heart wide open," said
Piotr Swat | Lightrocket | Getty Images An experimental lung cancer drug from Akeso and Summit Therapeutics reduced the risk of death by 34% in a closely watched late-stage trial, according to results released Sunday. When combined with chemotherapy, the drug kept people with squamous non-small-cell lung cancer alive for a median of four months
Marie Phelan said she had never heard of MDMA before spotting a flyer seeking veterans suffering from post traumatic stress disorder. Now, she says the psychoactive drug more commonly known as ecstasy or molly has changed the trajectory of her life. "My experience of MDMA was that it just cracked my heart wide open," said
Piotr Swat | Lightrocket | Getty Images An experimental lung cancer drug from Akeso and Summit Therapeutics reduced the risk of death by 34% in a closely watched late-stage trial, according to results released Sunday. When combined with chemotherapy, the drug kept people with squamous non-small-cell lung cancer alive for a median of four months
Marie Phelan said she had never heard of MDMA before spotting a flyer seeking veterans suffering from post traumatic stress disorder. Now, she says the psychoactive drug more commonly known as ecstasy or molly has changed the trajectory of her life. "My experience of MDMA was that it just cracked my heart wide open," said
Piotr Swat | Lightrocket | Getty Images An experimental lung cancer drug from Akeso and Summit Therapeutics reduced the risk of death by 34% in a closely watched late-stage trial, according to results released Sunday. When combined with chemotherapy, the drug kept people with squamous non-small-cell lung cancer alive for a median of four months
Marie Phelan said she had never heard of MDMA before spotting a flyer seeking veterans suffering from post traumatic stress disorder. Now, she says the psychoactive drug more commonly known as ecstasy or molly has changed the trajectory of her life. "My experience of MDMA was that it just cracked my heart wide open," said
Piotr Swat | Lightrocket | Getty Images An experimental lung cancer drug from Akeso and Summit Therapeutics reduced the risk of death by 34% in a closely watched late-stage trial, according to results released Sunday. When combined with chemotherapy, the drug kept people with squamous non-small-cell lung cancer alive for a median of four months
Marie Phelan said she had never heard of MDMA before spotting a flyer seeking veterans suffering from post traumatic stress disorder. Now, she says the psychoactive drug more commonly known as ecstasy or molly has changed the trajectory of her life. "My experience of MDMA was that it just cracked my heart wide open," said
Piotr Swat | Lightrocket | Getty Images An experimental lung cancer drug from Akeso and Summit Therapeutics reduced the risk of death by 34% in a closely watched late-stage trial, according to results released Sunday. When combined with chemotherapy, the drug kept people with squamous non-small-cell lung cancer alive for a median of four months
Marie Phelan said she had never heard of MDMA before spotting a flyer seeking veterans suffering from post traumatic stress disorder. Now, she says the psychoactive drug more commonly known as ecstasy or molly has changed the trajectory of her life. "My experience of MDMA was that it just cracked my heart wide open," said
Piotr Swat | Lightrocket | Getty Images An experimental lung cancer drug from Akeso and Summit Therapeutics reduced the risk of death by 34% in a closely watched late-stage trial, according to results released Sunday. When combined with chemotherapy, the drug kept people with squamous non-small-cell lung cancer alive for a median of four months
Marie Phelan said she had never heard of MDMA before spotting a flyer seeking veterans suffering from post traumatic stress disorder. Now, she says the psychoactive drug more commonly known as ecstasy or molly has changed the trajectory of her life. "My experience of MDMA was that it just cracked my heart wide open," said
Piotr Swat | Lightrocket | Getty Images An experimental lung cancer drug from Akeso and Summit Therapeutics reduced the risk of death by 34% in a closely watched late-stage trial, according to results released Sunday. When combined with chemotherapy, the drug kept people with squamous non-small-cell lung cancer alive for a median of four months
Marie Phelan said she had never heard of MDMA before spotting a flyer seeking veterans suffering from post traumatic stress disorder. Now, she says the psychoactive drug more commonly known as ecstasy or molly has changed the trajectory of her life. "My experience of MDMA was that it just cracked my heart wide open," said
Piotr Swat | Lightrocket | Getty Images An experimental lung cancer drug from Akeso and Summit Therapeutics reduced the risk of death by 34% in a closely watched late-stage trial, according to results released Sunday. When combined with chemotherapy, the drug kept people with squamous non-small-cell lung cancer alive for a median of four months
Kerry-Lynne Findlay Takes Helm of B.C.Conservative Party
After a fiercely competitive leadership contest, Kerry-Lynne Findlay has emerged as the new...
USPS Introduces New Rules for Tracking mail-In Ballots in Federal Elections
Introduction to USPS's Proposed Election Regulations
The United States Postal Service has unveiled a proposal...
Blue Origin’s New Glenn mega-rocket just exploded during testing at a launch site in Cape Canaveral, Florida, according to live streams from NASASpaceFlight.com and SpaceFlight Now. Blue Origin later confirmed the explosion. Jeff Bezos’ space company was performing a static fire test ahead of an anticipated fourth launch of the new rocket in the coming
Thea Energy has raised an oversubscribed $100 million Series B led by U.S. Innovative Technology Fund, the fusion startup told TechCrunch. The sum places the company among the better-funded fusion startups, giving it an improved chance at achieving a commercial reactor. The new funding will help Thea expand manufacturing for its uniquely designed smaller magnets
The Federal Aviation Administration (FAA) has ordered SpaceX to investigate why its Starship booster failed during the company’s May 22 test flight, according to a statement released to TechCrunch on Wednesday. This means SpaceX will have to pause any further Starship test launches until the investigation is completed and the results are submitted to the
Marie Phelan said she had never heard of MDMA before spotting a flyer seeking veterans suffering from post traumatic stress disorder. Now, she says the psychoactive drug more commonly known as ecstasy or molly has changed the trajectory of her life. "My experience of MDMA was that it just cracked my heart wide open," said
Piotr Swat | Lightrocket | Getty Images An experimental lung cancer drug from Akeso and Summit Therapeutics reduced the risk of death by 34% in a closely watched late-stage trial, according to results released Sunday. When combined with chemotherapy, the drug kept people with squamous non-small-cell lung cancer alive for a median of four months
I am sitting in the sweltering Nevada heat watching a man struggle to lift a bar over his head. If the man manages to do it, he will win $250,000. The man is Boady Santavy — a two-time Olympic weight-lifting contestant from Canada — and he has muscles that look culled from the Marvel Cinematic Universe: